Concord Drugs Share Price
BSE: 538965 | Pharmaceuticals | Small Cap
Concord Drugs Annualised Returns
Concord Drugs Annualised Returns
Concord Drugs Share Price Today
Concord Drugs Share Price Today
As of 22 Oct 2026, Concord Drugs share price is ₹66.8. The stock opened at ₹72.8 and had closed at ₹68 the previous day. During today’s trading session, Concord Drugs share price moved between ₹66.50 and ₹72.78, with an average price for the day of ₹69.64. Over the last 52 weeks, the stock has recorded a low of ₹61.00 and a high of ₹92.52. In terms of performance, Concord Drugs share price has declined by 20.3% over the past six months and has increased by 8.48% over the last year.
Concord Drugs Stock Performance
Concord Drugs Share Price Chart
Concord Drugs Share Price Chart
Concord Drugs Company background
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Concord Drugs Financial Highlights
For Q1 FY2026–2027, Concord Drugs's revenue reached ₹20.95 crore and profit touched at ₹1.11 crore. As of 22 October 2026, Concord Drugs’s market capitalization reached at ₹87.97 crores. Shareholding as of 22 October 2026 shows promoters holding 45.1% and public at 54.9%.
Concord Drugs Fundamental
Market Cap (in crs)
87.97
Face Value
10
Turnover (in lacs)
2.22
Key Metrics
Concord Drugs Key Financials
View moreConcord Drugs Result Highlights
- Concord Drugs reported a 123.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 264.4%.
- Its expenses for the quarter were up by 122.6% QoQ and 259.3% YoY.
- The net profit increased 140.9% QoQ and increased 1225.0% YoY.
- The earnings per share (EPS) of Concord Drugs stood at 0.47 during Q4 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Concord Drugs Technical Analysis
Delivery & Volume
Delivery Volume %
Day
85.50%
Week
76.30%
Month
79.60%
Resistance & Support
Concord Drugs Peer comparison
CompareIndex Name | Market Price |
|---|---|
49.46 +0.34 (+0.69%)▲ | |
61.08 -1.56 (-2.49%)▼ | |
740.00 -5.65 (-0.76%)▼ | |
66.77 -1.23 (-1.81%)▼ | |
7.33 -0.21 (-2.79%)▼ | |
92.00 +1.95 (+2.17%)▲ | |
118.54 +5.64 (+5.00%)▲ |
Concord Drugs Latest News
Concord Drugs Share Price FAQs
You can easily buy Concord Drugs shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Concord Drugs share price is ₹92.52 and ₹61 as of 21/10/2026.
Please be aware that Concord Drugs stock prices are subject to continuous fluctuations due to various factors.